What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.79%Below 5Y avg (1.79%)
Annual Rate
CNY 0.15Paid annual
Payout Ratio
115.7%High
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.71BCNY
550.36M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
48.69x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
649.30MCNY
96.43M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
11.69%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Beta
0.3150x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-8.35%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
3.71BCNY
550.36M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
3.31BCNY
491.70M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
48.69x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Sales (TTM)
5.71x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Book (MRQ)
3.45x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to Revenue
5.10x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to EBITDA
36.38x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 28.66×.Updated Aug 20, 2026
Gross Margin
21.50%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 26.36%.Updated Aug 20, 2026
Profit Margin
11.69%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Margin
6.10%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Assets (TTM)
2.58%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Equity (TTM)
6.39%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
649.30MCNY
96.43M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
3.33CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
7.80%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Profit (TTM)
171.14MCNY
25.42M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
115.50MCNY
17.15M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
75.92MCNY
11.28M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-27.40%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
56.22MCNY
8.35M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
-39.92MCNY
-5.93M · vs all stocks (USD)
Updated Aug 20, 2026
Trailing Annual Dividend Rate
0.1500CNYUpdated Aug 20, 2026
Trailing Annual Dividend Yield
0.79%
vs all stocks
Updated Aug 20, 2026
5-Year Average Dividend Yield
1.79%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
115.65%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 38.46%.Updated Aug 20, 2026
Minority Interest (Equity)
60.73MCNYFY2025 · Dec 31, 2025
Revenue
637.46MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
466.54MCNYFY2025 · Dec 31, 2025
Gross Profit
170.91MCNYFY2025 · Dec 31, 2025
Operating Income
73.83MCNY
10.96M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
87.58MCNYFY2025 · Dec 31, 2025
Income Tax Expense
10.69MCNYFY2025 · Dec 31, 2025
Net Income
76.88MCNYFY2025 · Dec 31, 2025
EBIT
87.82MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
110.45MCNYFY2025 · Dec 31, 2025
Research & Development
46.56MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
30.37MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.13MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.71MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
241.75KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4132CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4132CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
195.14MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
195.14MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
76.88MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
3.75MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
142.77MCNYFY2025 · Dec 31, 2025
Free Cash Flow
59.43MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
691.32MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
76.88MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
1.12MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
53.22MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
11.54MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-83.34MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-493.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
580.64MCNYFY2025 · Dec 31, 2025
Other Investing Activity
12.14MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
16.44MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
53.90MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-88.32MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-24.62MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-59.04MCNYFY2025 · Dec 31, 2025
Shares Outstanding
195.14MSharesUpdated Aug 20, 2026
Float Shares
96.51MSharesUpdated Aug 20, 2026
% Held by Insiders
57.21%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
1.52%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
542.06MCNY
80.51M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
2.78CNYUpdated Aug 20, 2026
Total Debt (MRQ)
86.66MCNY
12.87M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.0765x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Current Ratio (MRQ)
2.43x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
5.50CNYUpdated Aug 20, 2026
Total Assets
1.56BCNY
231.33M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.08BCNYFY2025 · Dec 31, 2025
Total Liabilities
436.53MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
474.27MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
60.07MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
376.46MCNYFY2025 · Dec 31, 2025
Cash
691.32MCNYFY2025 · Dec 31, 2025
Cash Equivalents
6.39MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
697.71MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
20.08MCNYFY2025 · Dec 31, 2025
Accounts Receivable
244.16MCNYFY2025 · Dec 31, 2025
Inventory
60.90MCNYFY2025 · Dec 31, 2025
Accounts Payable
333.00MCNYFY2025 · Dec 31, 2025
Short-term Debt
5.36MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
41.45KCNYFY2025 · Dec 31, 2025
Long-term Debt
54.08MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
195.14MCNYFY2025 · Dec 31, 2025
Retained Earnings
500.64MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.12BCNY
166.50M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
16.82CNYUpdated Aug 20, 2026
52-Week High
28.88CNYUpdated Aug 20, 2026
52-Week Change
-8.35%
vs all stocks
Updated Aug 20, 2026
Beta
0.3150x
vs all stocks
Updated Aug 20, 2026
50-Day MA
20.68CNYUpdated Aug 20, 2026
200-Day MA
20.71CNYUpdated Aug 20, 2026
Avg 10-Day Volume
3.17MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
3.56MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
0.3900CNYUpdated Aug 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 21.5%, lower than 95% of its Scientific & Technical Instruments peers (median 38.1%)Significant